Answer the question.As part of a broad effort to invigorate its pipeline and move more aggressively into biotechnology, a major pharmaceutical company plans to set up a new divisiondedicated to developing biotherapeutic drugs and research technologies. The company expects to pay $125 million for set up costs of its new division now and $7million operating costs each year for the next 13 years. The company estimates that the new division will be able to generate annual revenue of $42 millionbeginning 6 years from now. What is the conventional Benefit-to-Cost ratio for this investment if the company's discount rate is 9 % per year and the project life is13 years?Answer:

Name: Answer the question.As part of a broad effort to invigorate its pipel
Uploaded: 2022-11-30T03:40:23.000Z
Channel: Bartleby
Description: Answer the question.As part of a broad effort to invigorate its pipeline and move more aggressively into biotechnology, a major pharmaceutical company plans to set up a new divisiondedicated to developing biotherapeutic drugs and research technologi

Initial Cost (Setup Cost) = $125 million. Operating cost = $7 million per year Project Period = 13…

Business

Accounting

Answer the question. As part of a broad effort to invigorate its pipeline and move more aggressively into biotechnology, a major pharmaceutical dedicated to developing biotherapeutic drugs and research technologies. The company expects to pay $125 million for set million operating costs each year for the next 13 years. The company estimates that the new division will be able to generat beginning 6 years from now. What is the conventional Benefit-to-Cost ratio for this investment if the company's discount ra 13 years? Answer

Answer the question. As part of a broad effort to invigorate its pipeline and move more aggressively into biotechnology, a major pharmaceutical dedicated to developing biotherapeutic drugs and research technologies. The company expects to pay $125 million for set million operating costs each year for the next 13 years. The company estimates that the new division will be able to generat beginning 6 years from now. What is the conventional Benefit-to-Cost ratio for this investment if the company's discount ra 13 years? Answer

FINANCIAL ACCOUNTING

10th Edition

ISBN:9781259964947

Author:Libby

Publisher:Libby

Chapter1: Financial Statements And Business Decisions

Section: Chapter Questions

Problem 1Q

See similar textbooks

Similar questions

Quiet Quilts is considering adding another division that requires a cash outlay of $29,500, and is expected to generate $6,500 in after-tax cash flows each year for seven years. The CFO has determined the new division's beta coefficient is 0.8. The market return is expected to be 11 percent and the risk-free rate of return is 4 percent. Should Quiet add the new division? Show your work.
Typed please Please provide a quality solution for better ratings and take care of plagiarism also
You are an analyst working for Goldman Sachs, and you are trying to value the growth potential of a large, established company, Big Industries. Big Industries has a thriving R&D division that has consistently turned out successful products. You estimate that, on average, the division launches two projects every three years, so you estimate that there is a 61% chance that a project will be produced every year. Typically, the investment opportunities the R&D division produces require an initial investment of $9.8 million and yield profits of $1.06 million per year that grow at one of three possible growth rates in perpetuity: 2.6%, 0.0%, and -2.6%. All three growth rates are equally likely for any given project. These opportunities are always "take it or leave it" opportunities: If they are not undertaken immediately, they disappear forever. Assume that the cost of capital will always remain at 11.6% per year. What is the present value of all future growth opportunities Big Industries…
Solve: 1. Calculate the profitability index for each product. 2. Calculate the simple rate of return for each product. 3. Which of the two products should Lou's division pursue.
You are a consultant who has been hired to evaluate a new product line for Markum Enterprises. The upfront investment required to launch the product line is $11 million. The product will generate free cash flow of $0.76 million the first year, and this free cash flow is expected to grow at a rate of 6% per year. Markum has an equity cost of capital of 10.5%, a debt cost of capital of 5.04%, and a tax rate of 23%. Markum maintains a debt-equity ratio of 0.70. a. What is the NPV of the new product line (including any tax shields from leverage)? b. How much debt will Markum initially take on as a result of launching this product line? c. How much of the product line's value is attributable to the present value of interest tax shields? a. What is the NPV of the new product line (including any tax shields from leverage)? The NPV of the new product line is $ million. (Round to two decimal places.) C...
Database Systems is considering expansion into a new product line. Assets to support expansion will cost $740,000. It is estimated that Database can generate $1,910,000 in annual sales, with a 4 percent profit margin. What would net income and return on assets (investment) be for the year?
Since the beginning of the fiscal year 2009, Texas Department of Transportation invest one million each year to build up the transportation management database system in one of the Southern Texas city regions. TxDot is planning to transfer this database system to the city authority by the end of the fiscal year 2020. If the rate of return is 12% per year during the investment period, what is the total value of this database system when transferring?
Assuming PepsiCola, Atlanta is considering of giving its main rival a strong competition, in the launch of a product (two-in-one beverage) for a new market. The company requires an amount of $15,000,000.00 as the initial cost of plant/equipment for the products developed by its R&D research group to cover the project life cycle of eight years. For each year, 500,000 units would be produced. The selling price of a unit of the new product is $8.50. It is expected that in year two (2), the selling price of a unit will increase by 25%; year three (3) the unit will be selling by a further increase by 10% from year two (2)s selling price. From year four (4), the selling price will decrease by 5% from year three (3)s selling price and the subsequent years will stabilize or remain till the end of the project life and further. The production department estimated cost of each unit for 1st year as $2.75, it will increase in 2nd year by 25%; In the 3rd year, will increase by 10% from the…
Robust Ventures is planning to expand its production operation. It has identified three different technologies for meeting the goal. The initial investment and annual revenues with respect to each of the technologies are summarized in table below. Suggest the best technology which is to be implemented based on the future worth method of comparison assuming 20% interest rate, compounded annually. Annual Revenue (Php) Initial Life Investment (years) (Php) Technology X 1,200,000 400,000 10 Technology Y 2,000,000 600,000 10 Technology Z 1,800,000 500,000 a. Technology X since it has the highest revenue. O b. Technology X since it is the least costly. c. Technology Z since it has the highest revenue. O d. Technology Y since it has the highest revenue. 10
The company is looking to invest $800,000 for two addition lines for production. Our current ROI targets are at 15%. These two lines would then produce annual profits of $65,000 for each line. Do you think the company should move forward with this purchase?
You are the CFO of a drug company, and you must decide whether to invest 30 million dollars in R&D for a new drug. If you conduct the R&D, you believe that there is a 10% chance that the research will produce a useful drug. If the research is successful, investment in the drug will require an outlay of 1.2 billion dollars. The drug will likely generate annual profits of $200 million (starting a year after the outlay of 1.2 billion dollars) for 10 years until the patent expires. After that, it will generate a cash flow in perpetuity equal to $15 million. The discount rate is 6%. If you invest in R&D, you estimate that it will take 5 years to know whether the drug is successful or not. What is the NPV of the R&D investment?
The current controllable margin for Henry Division is $93,000. Its current operating assets are $300,000. The division is considering purchasing equipment for $90,000 that will increase annual controllable margin by an estimated $15,000. If the equipment is purchased, what will happen to the return on investment for Henry Division?